CIMAvax reportedly works by stimulating the body’s own immune system to attack epidermal growth factor, a naturally occurring protein that can feed cancerous tumors. Since 2011, the vaccine has been available for free to the public in Cuba. It also has been approved for use in Peru. According to media reports, the vaccine shows promise … Read more
Cuba’s Cimavax gained media attention last month when Roswell Park Cancer Institute in Buffalo, New York announced that the U.S. Food and Drug Administration (FDA) had approved clinical trials there as part of a collaboration with Cuba’s Center for Molecular Immunology. But there are actually two parallel medical initiatives pursuing commercialization of the human cancer … Read more
Yesterday, Cuba and the U.S. signed a memorandum of understanding for collaboration around cancer. The agreement, signed by Dr. Roberto Morales Ojeda, Cuban Minister of Public Health, and Sylvia Burwell, Secretary of the U.S. Health and Human Services, seeks to combine forces to combat cancer through collaboration. Joint meetings, conferences and workshops will promoting exchange … Read more
